e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Developments in lung cancer diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Number of procedures and time needed to diagnose lung cancer: Being right the first time
Jonathen Venkatachalam (Singapore, Singapore), Akash Verma, Jonathen Venkatachalam, Dessmon Tai, Soon Keng Goh, Ai Ching Kor, Albert Lim, John Abisheganaden
Source:
International Congress 2015 – Developments in lung cancer diagnosis
Session:
Developments in lung cancer diagnosis
Session type:
Poster Discussion
Number:
2991
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jonathen Venkatachalam (Singapore, Singapore), Akash Verma, Jonathen Venkatachalam, Dessmon Tai, Soon Keng Goh, Ai Ching Kor, Albert Lim, John Abisheganaden. Number of procedures and time needed to diagnose lung cancer: Being right the first time. Eur Respir J 2015; 46: Suppl. 59, 2991
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Imaging of eosinophilic lung disease
Related content which might interest you:
Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
National lung cancer tissue diagnosis targets: Are they achievable?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Predictors of lung cancer patients delay time in Serbia - a cross-sectional study
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Diagnosing lung cancer: Choosing the best for your patient
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Assessing the local impact of a national lung cancer awareness campaign
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Symptom occurrence in lung cancer patients prior to surgery
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Lung cancer, has it changed in the last ten years?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Hospitalization costs of lung cancer diagnosis in Turkey: Is there a difference between histological types and stages?
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
The two week wait pathway: Is it used appropriately?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Validating an EBUS service provided by a group of operators with different levels of experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Does the type of N1 state different survival
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
A feasibility study: Home-telemonitoring for rural lung cancer patients
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept